HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Puig acquires fragrance license

This article was originally published in The Rose Sheet

Executive Summary

Comme des Garcons fragrance distribution will expand in top-tier retail stores such as Saks Fifth Avenue and Neiman Marcus under direction of Puig, USA President and General Manager, North America Beauty Kathy Cullin says. Puig, which announced agreement with the fashion house Sept. 13, said expansion will begin by the end of 2003. Comme des Garcons, which currently markets 25 scents, including Comme des Garcons, Comme des Garcons 2, Series 1: Leaves andSeries 2: Red, said it generated $2 mil. in sales in 2001 and expects $2.6 mil. this year (1"The Rose Sheet" April 29, 2002, p. 8)...

You may also be interested in...



Comme des Garcons Readies 3 Fragrance Launches

Comme des Garcons Parfums is planning a trio of fragrance launches including Comme des Garcons 3 and the five-SKU, limited-distribution Series 3: Incense collection, according to General Director Adrian Joffe

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010621

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel